Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Cross Country Healthcare (CCRN) EPS (Weighted Average and Diluted) (2016 - 2025)

Cross Country Healthcare's EPS (Weighted Average and Diluted) history spans 16 years, with the latest figure at -$2.56 for Q4 2025.

  • For Q4 2025, EPS (Weighted Average and Diluted) fell 2033.33% year-over-year to -$2.56; the TTM value through Dec 2025 reached -$2.93, down 581.4%, while the annual FY2025 figure was -$2.93, 565.91% down from the prior year.
  • EPS (Weighted Average and Diluted) reached -$2.56 in Q4 2025 per CCRN's latest filing, down from -$0.15 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $2.07 in Q4 2021 to a low of -$2.56 in Q4 2025.
  • Average EPS (Weighted Average and Diluted) over 5 years is $0.36, with a median of $0.34 recorded in 2021.
  • Peak YoY movement for EPS (Weighted Average and Diluted): soared 1650.0% in 2021, then tumbled 2033.33% in 2025.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at $2.07 in 2021, then tumbled by 49.28% to $1.05 in 2022, then tumbled by 75.24% to $0.26 in 2023, then plummeted by 146.15% to -$0.12 in 2024, then tumbled by 2033.33% to -$2.56 in 2025.
  • Per Business Quant, the three most recent readings for CCRN's EPS (Weighted Average and Diluted) are -$2.56 (Q4 2025), -$0.15 (Q3 2025), and -$0.2 (Q2 2025).